Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-03-002124
Filing Date
2003-03-31
Accepted
2003-03-31 16:12:14
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K DATED 12/31/02 b45660hie10vk.htm 10-K 1015697
3 EX-10.12 CONSULTING AGREEMENT b45660hiexv10w12.txt EX-10.12 7517
4 EX-10.42 AMEND 1 TO COLLABORATION AGREEMENT b45660hiexv10w42.txt EX-10.42 5113
5 EX-10.43 LICENSE AND ROYALTY AGREEMENT b45660hiexv10w43.txt EX-10.43 59465
6 EX-23.2 CONSENT OF ERNST AND YOUNG LLP b45660hiexv23w2.txt EX-23.2 707
7 EX-99.1 CERTIFICATION OF CEO b45660hiexv99w1.txt EX-99.1 1330
8 EX-99.2 CERTIFICATION OF CFO b45660hiexv99w2.txt EX-99.2 1322
9 FORM 10-K DATED 12/31/02 PDF b45660hie10vkxpdfy.pdf 10-K 891233
  Complete submission text file 0000950135-03-002124.txt   1984864
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
HYBRIDON INC (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27352 | Film No.: 03630915
SIC: 2836 Biological Products, (No Diagnostic Substances)